The Effectiveness of Combination of Viola odorata L., Rosa damascena Mill. and Coriandrum sativum L. on Quality of Life of Patients with Migraine Headaches: A Randomized, Double Blinded, Placebo-Controlled Clinical Trial
Headache is one of the most common public health problems in the world, which causes patients to see a doctor. Migraine is the second most common cause of headaches after tension headaches. This study is a randomized, double blinded, placebo - controlled clinical trial, using SF36 questionnaire, to evaluate the effect of combination of Viola odorata L., Rosa damascena Mill. and Coriandrum sativum L. on the quality of life, in patients with migraine after 4 weeks. In all domains of the SF36 questionnaire, the scores after intervention in the drug group were significantly higher than the control group after 4 weeks. This study showed that, combination of V. odorata, R. damascena and C. sativum, improves the quality of life of patients with migraine.
Nemati Karimavi H, Rakhshande H, Esmaeili H. Study of effect of tanastum partenium on treatment of migraine. Med J Mashhad Univ Med Sci 2007;50:333-338.
Sances G, Catarci T. Management of Headache Patients. In: Aminoff's Neurology and General Medicine. MJ. Elsevier 2010; pp 127-135.
Huguet A, Tougas ME, Hayden J, McGrath PJ, Chambers CT, Stinson JN. Systematic review of childhood and adolescent risk and prognostic factors for recurrent headaches. J Pain 2016; 17:855-873.
Lee J, Bhowmick A, Wachholtz A. Does complementary and alternative medicine (CAM) use reduce negative life impact of headaches for chronic migraine: A national survey. SpringerPlus 2016;1006:112-114.
Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci 2015;35:6619-6629.
Garza I, Swanson JW, Cheshire WPJr, Boes CJ, Capobianco DJ. Headache and Other Craniofacial Pain. In: Bradley Neurology in Clinical Practice. Elsevier. Philadelphia 2012; pp 1703-1743.
Wang SJ, Chen PK, Fuh JL. Comorbidities of Migraine. Front Neurol 2010;1:16.
Essink-Bot ML, van Royen L, Krabbe P, Bonsel GJ, Rutten FF. The impact of migraine on health status. Headache 1995;35:200-206.
Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF. Migraine, quality of life, and depression: a population-based case-control study. Neurology 2000;55:629-635.
Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF. Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 2003;23:441-450.
Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population. Neurology 2000;55:624-629.
Ayatolahi MT, Ahmad K. The prevalence of migraine and tension headache and its correlates among schoolchildren in Shiraz. JBUMS 2003;29:78-85.
Holroyd KA1, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L. Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ 2010;341:c4871.
Noyez L. Quality of life research, it’s only the beginning. Neth Heart J 2013;21:19-20.
Solomon GD. Evolution of the measurement of quality of life in migraine. Neurology 1997; 48:10-15.
Brandes J, Kudrow D, Rothrock J, Rupnow MF, Fairclough D, Greenberg S. Assessing the ability of topiramate to improve the daily activities of patients with migraine. Mayo Clin Proc 2006;81:1311-1319.
Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: measurements by the medical outcomes study instrument. Headache 1993;33:351-358.
Gandek B, Sinclair SJ, Kosinski M, Ware JE. Psychometric evaluation of the SF-36® health survey in medicare managed care. Health Care Financ Rev 2004;25:5-25.
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care 1992;30:473-483.
McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–263.
Brandes JL, Saper JR, Diamond M. MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004:291:965-973.
Osterhaus JT, Townsend RJ, Gandek B, Ware JE. Measuring the functional status and well-being of patients with migraine headache. Headache 1994;34:337-343.
Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003;4:386-898.
Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W. Adverse reactions to antidepressants. BJPsych 2009;195:202-210.
Zhang M, Liu Y, Zhao M, Tang W, Wang X, Dong Z. Depression and anxiety behavior in a rat model of chronic migraine. J Headache Pain 2017;18:27.
Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iran J Neurol 2012;11:21-24.
Wells RE, Bertisch SM, Buettne C, Phillip RS, McCarthy. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache 2011;51:1087-1097.
Pal S, Shukla Y. Herbal medicine: current status and the future. Asian Pac J Cancer Prev 2003;4:281-288.
Zarshenas MM, Firoozabadi A, Petramfar P, Moein MR, Mohagheghzadeh A. Types of headache and those remedies in traditional persian medicine. Pharmacogn Rev 2013;7:17.
Gorji A. Pharmacological treatment of headache using traditional Persian medicine. Trends Pharmacol Sci 2003;24:331-334.
Jafarpour M, Yousefi G, Hamedi A. A review of herbal medicine in iranian traditional manuscripts for treatment of participatory gastric headache. Iran J Med Sci 2016;41:17.
Avicenna. The Cannon of Medicine. Sorush. Tehran 1983; pp 2-196.
Aghili Khorasani MH. Makhzan-al Adviyah. Tehran University of Medical Sciences. Tehran 2013; p 260,687,803.
Chashti H. Exir-e-Azam. Thran University of Medical Sciences. Tehran 2008; pp 174-178.
A’azam khan M. Gharabadin-e azam va akmal. AL-Maei. Tehran 2014; p 369.
Karim khan kermani H. Daqaeq- al- Alaj. Chogan. Tehran 2016; p 233.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd ed. Cephalalgia 2013;33:629-808.
Kavian Q. Overlapping of primary headaches. JBUMS 2002;14:26-29.
Kamali M, Seifadini R, Kamali H, Mehrabani M, Jahani Y, Tajadini H. Efficacy of combination of V. odorata, R. damascena and C. sativum in prevention of migraine attacks: a randomized, double blind, placebo-controlled clinical trial. Electron Physician 2018;10:6430-6438.
Montazeri A, Goshtasbi A, Vahdaninia MAS. The short form health survey (SF-36): translation and validation study of the iranian version. Qual Life Res 2006;5:49-56.
World Medical Association Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects. WMA General Assembly. Fortaleza, Brazil. JAMA 2013;59:199-202.
Fallah R, Divanizadeh M, Karimi M, Ordooei M .Evaluation of efficacy and safety of propranolol for pediatric migraine prophylaxis. JMED 2013;80:920-924.
Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the american migraine prevalence and prevention (AMPP) Study. Headache 2013;53:1278-1299.
Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 2017;16:76-87.
Ozdemir G, Aygul R, Demir R, Ozel L, Ertekin A, Ulvi H. Migraine prevalence, disability, and sociodemographic properties in the eastern region of Turkey: a population-based door-to-door survey. Turk J Med Sci 2014;44:10-16.
Ramage-Morin PL, Gilmour H. Prevalence of migraine in the Canadian household population. Health Rep 2014;25:10-16.
Ware JE, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. QualityMetric. 2003.
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev 2017;97:553-622.
Emami A, Fasihi S, Mehregan I. PDR for herbal medicine. 4th ed. Andishe. Tehran 2010; pp 1496-1498.
Mittal P, Gupta V, Goswami M, Thakur N, Bansal P. Phytochemical and pharmacological potential of viola odorata. IJP 2015;4:693.
Feyzabadi Z, Jafari F, Kamali SH, Ashayeri H, Badiee Aval S, Esfahani MM, Sadeghpour O. Efficacy of V. odorata in Treatment of Chronic Insomnia. Iran Red Crescent Med J 2014;16:e17511.
Antil V, Kumar P, Kannappan N, Diwan A, Saini P, Singh, S. Evaluation of the analgesic activity of V. odorata aerial parts in rats. J Nat Pharm 2011;2:24.
Monadi, A, Rezaie A. Evaluation of sedative and pre-anesthetic effects of V. odorata Linn. extract compared with diazepam in rats. Bull Env Pharmacol Life Sci 2013;2:125-131.
Emami A, Fasihi S, Mehregan I. PDR for herbal medicine. 4th ed. Andishe. Tehran 2010; pp 400-402.
Delavar Kasmaei H, Ghorbanifar Z, Zayeri F, Minaei B, Kamali SH, Rezaeizadeh H, Amin GR, Ghobadi A, Mirzaei Z. Effects of C. sativum Syrup on Migraine: A Randomized, Triple-Blind, Placebo-Controlled Trial. Iran Red Crescent Med J 2016;18:e20759.
Rakhshandeh H, Vahdati-Mashhadian N, Dolati KHM. Antinociceptive effect of R. damascena in Mice. Int J Biol Sci 2008;8:176-180.
|Issue||Vol 4, No 4, 2019|
|Persian medicine; Viola; Migraine; Headache; SF36; Traditional iranian medicine; Complementary and alternative medicine (CAM); Quality of life|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|